Today's Veterinary Business

FEB 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link: https://todaysveterinarybusiness.epubxp.com/i/943290

Contents of this Issue

Navigation

Page 66 of 67

IMPORTANT SAFETY INFORMATION: NexGard ® (afoxolaner) is for use in dogs only. The most frequently reported adverse reactions included pruritus, vomiting, dry/fl aky skin, diarrhea, lethargy, and lack of appetite. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. For more information, see full prescribing information or visit www.NexGardForDogs.com. Preferred by dogs 1 and dog owners 2 – NexGard® (afoxolaner) makes it easy to protect your canine patients against fl eas and four of the most common species of ticks in North America. 1 Data on fi le at Merial. 2 Data on fi le at Merial. Based on veterinary dispensed dose data. NexGard is a Merial product. Merial is now part of Boehringer Ingelheim. NexGard ® is a registered trademark, and FRONTLINE VET LABS TM is a trademark, of Merial. ©2017 Merial, Inc., Duluth, GA. All rights reserved. NEX18TRADEAD1 (01/18). Make killing fl eas & ticks

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - FEB 2018